• Recommended for the treatment of stent restenosis, small vessel disease, and branch lesions.
• Clinical evidence supports primary coronary artery lesions such as macrovascular lesions.
• Improved PEBAX guarantees higher flexibility and enhanced crossability
• Loaded Paclitaxel inhibits restenosis continuously.
• Coated with Active Pharmaceutical Ingredients grade urea, provide better biocompatibility, facilitate drug-releasing effectively.
• Spiral cut hypotube design, strengthen the transition section, bring optimized deliverability for transition.
NC Tadpole™Read more
Xperience proRead more
NC xperienceRead more
Essential proRead more
Rise™ NCRead more
Pantera ProRead more
Pantera LeoRead more
Pantera LuxRead more
Scoreflex NCRead more
Sapphire II PRO (1.0 mm – 1.5 mm)Read more
Sapphire 3 (0.85 mm – 1.25 mm)Read more
Sapphire II NCRead more
Sapphire NC24Read more
Sapphire II PRO (1.75 mm – 4.0 mm)Read more
Sapphire 3 (1.5 mm – 4.0 mm)Read more